nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP1A2—Carmustine—malignant glioma	0.268	0.57	CbGbCtD
Rifabutin—CYP3A4—Temozolomide—malignant glioma	0.203	0.431	CbGbCtD
Rifabutin—HSP90AA1—pons—malignant glioma	0.025	0.155	CbGeAlD
Rifabutin—HSP90AA1—pineal body—malignant glioma	0.0178	0.111	CbGeAlD
Rifabutin—HSP90AA1—endothelium—malignant glioma	0.011	0.0686	CbGeAlD
Rifabutin—HSP90AA1—blood vessel—malignant glioma	0.0102	0.0633	CbGeAlD
Rifabutin—HSP90B1—embryo—malignant glioma	0.0083	0.0516	CbGeAlD
Rifabutin—HSP90B1—brainstem—malignant glioma	0.0076	0.0473	CbGeAlD
Rifabutin—HSP90B1—retina—malignant glioma	0.00734	0.0456	CbGeAlD
Rifabutin—HSP90B1—telencephalon—malignant glioma	0.00675	0.042	CbGeAlD
Rifabutin—HSP90AA1—embryo—malignant glioma	0.00607	0.0378	CbGeAlD
Rifabutin—HSP90AA1—brainstem—malignant glioma	0.00556	0.0346	CbGeAlD
Rifabutin—HSP90AA1—retina—malignant glioma	0.00536	0.0334	CbGeAlD
Rifabutin—HSP90B1—medulla oblongata—malignant glioma	0.0053	0.033	CbGeAlD
Rifabutin—HSP90AA1—telencephalon—malignant glioma	0.00493	0.0307	CbGeAlD
Rifabutin—HSP90B1—midbrain—malignant glioma	0.00485	0.0301	CbGeAlD
Rifabutin—HSP90B1—spinal cord—malignant glioma	0.00473	0.0294	CbGeAlD
Rifabutin—HSP90AA1—medulla oblongata—malignant glioma	0.00388	0.0241	CbGeAlD
Rifabutin—HSP90B1—central nervous system—malignant glioma	0.00384	0.0239	CbGeAlD
Rifabutin—HSP90B1—cerebellum—malignant glioma	0.00375	0.0233	CbGeAlD
Rifabutin—HSP90AA1—midbrain—malignant glioma	0.00354	0.022	CbGeAlD
Rifabutin—HSP90AA1—spinal cord—malignant glioma	0.00346	0.0215	CbGeAlD
Rifabutin—Lymphopenia—Temozolomide—malignant glioma	0.00345	0.0583	CcSEcCtD
Rifabutin—HSP90B1—brain—malignant glioma	0.00305	0.0189	CbGeAlD
Rifabutin—Aphasia—Carmustine—malignant glioma	0.00281	0.0476	CcSEcCtD
Rifabutin—HSP90AA1—central nervous system—malignant glioma	0.0028	0.0175	CbGeAlD
Rifabutin—HSP90AA1—cerebellum—malignant glioma	0.00274	0.0171	CbGeAlD
Rifabutin—Aphasia—Temozolomide—malignant glioma	0.00272	0.046	CcSEcCtD
Rifabutin—HSP90AA1—brain—malignant glioma	0.00223	0.0139	CbGeAlD
Rifabutin—Rifampicin—CYP2B6—malignant glioma	0.00207	1	CrCbGaD
Rifabutin—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00187	0.0315	CcSEcCtD
Rifabutin—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00176	0.0298	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00147	0.0249	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00115	0.0195	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00113	0.0191	CcSEcCtD
Rifabutin—Pancytopenia—Carmustine—malignant glioma	0.00109	0.0184	CcSEcCtD
Rifabutin—Neutropenia—Carmustine—malignant glioma	0.00107	0.0181	CcSEcCtD
Rifabutin—Pancytopenia—Temozolomide—malignant glioma	0.00105	0.0178	CcSEcCtD
Rifabutin—Neutropenia—Temozolomide—malignant glioma	0.00103	0.0175	CcSEcCtD
Rifabutin—Hepatobiliary disease—Temozolomide—malignant glioma	0.000933	0.0158	CcSEcCtD
Rifabutin—Connective tissue disorder—Carmustine—malignant glioma	0.000901	0.0152	CcSEcCtD
Rifabutin—Hepatitis—Temozolomide—malignant glioma	0.000886	0.015	CcSEcCtD
Rifabutin—Connective tissue disorder—Temozolomide—malignant glioma	0.000871	0.0147	CcSEcCtD
Rifabutin—Eye disorder—Carmustine—malignant glioma	0.000857	0.0145	CcSEcCtD
Rifabutin—Eye disorder—Temozolomide—malignant glioma	0.000828	0.014	CcSEcCtD
Rifabutin—Immune system disorder—Temozolomide—malignant glioma	0.0008	0.0135	CcSEcCtD
Rifabutin—Dysgeusia—Temozolomide—malignant glioma	0.000755	0.0128	CcSEcCtD
Rifabutin—Anaemia—Carmustine—malignant glioma	0.000738	0.0125	CcSEcCtD
Rifabutin—Leukopenia—Carmustine—malignant glioma	0.000714	0.0121	CcSEcCtD
Rifabutin—Anaemia—Temozolomide—malignant glioma	0.000713	0.0121	CcSEcCtD
Rifabutin—Convulsion—Carmustine—malignant glioma	0.000691	0.0117	CcSEcCtD
Rifabutin—Leukopenia—Temozolomide—malignant glioma	0.00069	0.0117	CcSEcCtD
Rifabutin—Myalgia—Carmustine—malignant glioma	0.000679	0.0115	CcSEcCtD
Rifabutin—Chest pain—Carmustine—malignant glioma	0.000679	0.0115	CcSEcCtD
Rifabutin—Convulsion—Temozolomide—malignant glioma	0.000668	0.0113	CcSEcCtD
Rifabutin—Confusional state—Carmustine—malignant glioma	0.000657	0.0111	CcSEcCtD
Rifabutin—Myalgia—Temozolomide—malignant glioma	0.000657	0.0111	CcSEcCtD
Rifabutin—Arthralgia—Temozolomide—malignant glioma	0.000657	0.0111	CcSEcCtD
Rifabutin—CYP3A4—central nervous system—malignant glioma	0.000656	0.00408	CbGeAlD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000652	0.011	CcSEcCtD
Rifabutin—Thrombocytopenia—Carmustine—malignant glioma	0.000638	0.0108	CcSEcCtD
Rifabutin—Confusional state—Temozolomide—malignant glioma	0.000635	0.0107	CcSEcCtD
Rifabutin—Anorexia—Carmustine—malignant glioma	0.000621	0.0105	CcSEcCtD
Rifabutin—Thrombocytopenia—Temozolomide—malignant glioma	0.000616	0.0104	CcSEcCtD
Rifabutin—Skin disorder—Temozolomide—malignant glioma	0.000611	0.0103	CcSEcCtD
Rifabutin—Anorexia—Temozolomide—malignant glioma	0.0006	0.0101	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000593	0.01	CcSEcCtD
Rifabutin—Insomnia—Carmustine—malignant glioma	0.000589	0.00996	CcSEcCtD
Rifabutin—Paraesthesia—Carmustine—malignant glioma	0.000585	0.00989	CcSEcCtD
Rifabutin—Dyspnoea—Carmustine—malignant glioma	0.000581	0.00982	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000573	0.0097	CcSEcCtD
Rifabutin—Insomnia—Temozolomide—malignant glioma	0.000569	0.00962	CcSEcCtD
Rifabutin—Decreased appetite—Carmustine—malignant glioma	0.000566	0.00957	CcSEcCtD
Rifabutin—Paraesthesia—Temozolomide—malignant glioma	0.000565	0.00956	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Carmustine—malignant glioma	0.000562	0.00951	CcSEcCtD
Rifabutin—Dyspnoea—Temozolomide—malignant glioma	0.000561	0.00949	CcSEcCtD
Rifabutin—Pain—Carmustine—malignant glioma	0.000557	0.00942	CcSEcCtD
Rifabutin—Dyspepsia—Temozolomide—malignant glioma	0.000554	0.00937	CcSEcCtD
Rifabutin—Decreased appetite—Temozolomide—malignant glioma	0.000547	0.00925	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000543	0.00919	CcSEcCtD
Rifabutin—Pain—Temozolomide—malignant glioma	0.000538	0.0091	CcSEcCtD
Rifabutin—Feeling abnormal—Carmustine—malignant glioma	0.000537	0.00907	CcSEcCtD
Rifabutin—Gastrointestinal pain—Carmustine—malignant glioma	0.000533	0.009	CcSEcCtD
Rifabutin—Feeling abnormal—Temozolomide—malignant glioma	0.000519	0.00877	CcSEcCtD
Rifabutin—Body temperature increased—Carmustine—malignant glioma	0.000515	0.00871	CcSEcCtD
Rifabutin—Abdominal pain—Carmustine—malignant glioma	0.000515	0.00871	CcSEcCtD
Rifabutin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000515	0.0087	CcSEcCtD
Rifabutin—Abdominal pain—Temozolomide—malignant glioma	0.000498	0.00841	CcSEcCtD
Rifabutin—Body temperature increased—Temozolomide—malignant glioma	0.000498	0.00841	CcSEcCtD
Rifabutin—Hypersensitivity—Carmustine—malignant glioma	0.00048	0.00811	CcSEcCtD
Rifabutin—Asthenia—Carmustine—malignant glioma	0.000467	0.0079	CcSEcCtD
Rifabutin—Hypersensitivity—Temozolomide—malignant glioma	0.000464	0.00784	CcSEcCtD
Rifabutin—Asthenia—Temozolomide—malignant glioma	0.000452	0.00764	CcSEcCtD
Rifabutin—Diarrhoea—Carmustine—malignant glioma	0.000446	0.00753	CcSEcCtD
Rifabutin—Pruritus—Temozolomide—malignant glioma	0.000445	0.00753	CcSEcCtD
Rifabutin—Diarrhoea—Temozolomide—malignant glioma	0.000431	0.00728	CcSEcCtD
Rifabutin—Vomiting—Carmustine—malignant glioma	0.000414	0.007	CcSEcCtD
Rifabutin—Rash—Carmustine—malignant glioma	0.000411	0.00694	CcSEcCtD
Rifabutin—Dermatitis—Carmustine—malignant glioma	0.00041	0.00694	CcSEcCtD
Rifabutin—Headache—Carmustine—malignant glioma	0.000408	0.0069	CcSEcCtD
Rifabutin—Vomiting—Temozolomide—malignant glioma	0.0004	0.00677	CcSEcCtD
Rifabutin—Rash—Temozolomide—malignant glioma	0.000397	0.00671	CcSEcCtD
Rifabutin—Dermatitis—Temozolomide—malignant glioma	0.000396	0.0067	CcSEcCtD
Rifabutin—Headache—Temozolomide—malignant glioma	0.000394	0.00667	CcSEcCtD
Rifabutin—Nausea—Carmustine—malignant glioma	0.000387	0.00654	CcSEcCtD
Rifabutin—Nausea—Temozolomide—malignant glioma	0.000374	0.00632	CcSEcCtD
Rifabutin—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	8.76e-05	0.000285	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—AKT1—malignant glioma	8.74e-05	0.000284	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HIST1H3B—malignant glioma	8.66e-05	0.000282	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—FGF2—malignant glioma	8.63e-05	0.000281	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTT1—malignant glioma	8.62e-05	0.000281	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDKN2A—malignant glioma	8.62e-05	0.000281	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	8.62e-05	0.00028	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—VEGFA—malignant glioma	8.59e-05	0.00028	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IFNA2—malignant glioma	8.36e-05	0.000272	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—AKT2—malignant glioma	8.29e-05	0.00027	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTT1—malignant glioma	8.19e-05	0.000266	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS1—malignant glioma	8.08e-05	0.000263	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—RAF1—malignant glioma	8.05e-05	0.000262	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—STAT3—malignant glioma	8e-05	0.00026	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—ERBB2—malignant glioma	7.96e-05	0.000259	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PIK3CD—malignant glioma	7.96e-05	0.000259	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	7.93e-05	0.000258	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—JAG2—malignant glioma	7.91e-05	0.000257	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	7.76e-05	0.000252	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	7.76e-05	0.000252	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—EGFR—malignant glioma	7.73e-05	0.000252	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDKN2A—malignant glioma	7.71e-05	0.000251	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—PTGS1—malignant glioma	7.67e-05	0.00025	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—TP53—malignant glioma	7.65e-05	0.000249	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—FGF2—malignant glioma	7.62e-05	0.000248	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—BCHE—malignant glioma	7.51e-05	0.000244	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MDM2—malignant glioma	7.48e-05	0.000243	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—RTEL1—malignant glioma	7.43e-05	0.000242	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—SLC5A5—malignant glioma	7.42e-05	0.000241	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	7.39e-05	0.00024	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	7.39e-05	0.00024	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—GSTP1—malignant glioma	7.35e-05	0.000239	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	7.33e-05	0.000238	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—KRAS—malignant glioma	7.31e-05	0.000238	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PTK2—malignant glioma	7.27e-05	0.000237	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—EGFR—malignant glioma	7.27e-05	0.000237	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	7.25e-05	0.000236	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—BCL2—malignant glioma	7.24e-05	0.000236	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—MDM2—malignant glioma	7.13e-05	0.000232	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—RAF1—malignant glioma	7.11e-05	0.000231	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—ERBB2—malignant glioma	7.03e-05	0.000229	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PIK3CB—malignant glioma	6.94e-05	0.000226	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CDKN2B—malignant glioma	6.92e-05	0.000225	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—KRAS—malignant glioma	6.87e-05	0.000224	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MMP9—malignant glioma	6.83e-05	0.000222	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PDGFRA—malignant glioma	6.8e-05	0.000221	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HLA-B—malignant glioma	6.76e-05	0.00022	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—H3F3A—malignant glioma	6.69e-05	0.000218	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCR3—malignant glioma	6.63e-05	0.000216	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HES1—malignant glioma	6.6e-05	0.000215	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NCOR1—malignant glioma	6.56e-05	0.000213	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—YWHAE—malignant glioma	6.45e-05	0.00021	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NTRK2—malignant glioma	6.45e-05	0.00021	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FLT1—malignant glioma	6.42e-05	0.000209	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—DUSP6—malignant glioma	6.39e-05	0.000208	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PIK3CA—malignant glioma	6.31e-05	0.000205	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—JAG1—malignant glioma	6.31e-05	0.000205	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOTCH3—malignant glioma	6.28e-05	0.000204	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PDGFRA—malignant glioma	6.28e-05	0.000204	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HLA-A—malignant glioma	6.26e-05	0.000204	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FBXW7—malignant glioma	6.18e-05	0.000201	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—VEGFA—malignant glioma	6.13e-05	0.0002	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PDGFB—malignant glioma	6.11e-05	0.000199	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—FGFR1—malignant glioma	6.08e-05	0.000198	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—STAT3—malignant glioma	6.07e-05	0.000198	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—BDKRB2—malignant glioma	6.06e-05	0.000197	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PTEN—malignant glioma	6e-05	0.000195	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTP1—malignant glioma	5.98e-05	0.000195	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MYC—malignant glioma	5.84e-05	0.00019	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CAT—malignant glioma	5.82e-05	0.000189	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HLA-A—malignant glioma	5.78e-05	0.000188	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TERT—malignant glioma	5.78e-05	0.000188	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—RTEL1—malignant glioma	5.74e-05	0.000187	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTP1—malignant glioma	5.67e-05	0.000185	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PDGFB—malignant glioma	5.64e-05	0.000184	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOTCH2—malignant glioma	5.63e-05	0.000183	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—FGFR1—malignant glioma	5.61e-05	0.000183	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	5.6e-05	0.000182	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HIF1A—malignant glioma	5.53e-05	0.00018	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—EGFR—malignant glioma	5.52e-05	0.00018	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KNG1—malignant glioma	5.51e-05	0.000179	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—NCOR1—malignant glioma	5.49e-05	0.000179	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—BAD—malignant glioma	5.45e-05	0.000177	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CAV1—malignant glioma	5.35e-05	0.000174	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	5.31e-05	0.000173	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD80—malignant glioma	5.28e-05	0.000172	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TNF—malignant glioma	5.26e-05	0.000171	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NTRK1—malignant glioma	5.26e-05	0.000171	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MYC—malignant glioma	5.22e-05	0.00017	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGF—malignant glioma	5.21e-05	0.00017	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—KRAS—malignant glioma	5.21e-05	0.00017	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PTPN11—malignant glioma	5.18e-05	0.000169	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—AKT1—malignant glioma	5.16e-05	0.000168	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	5.14e-05	0.000167	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—BAD—malignant glioma	5.03e-05	0.000164	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NOTCH1—malignant glioma	4.98e-05	0.000162	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MMP3—malignant glioma	4.89e-05	0.000159	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CD80—malignant glioma	4.88e-05	0.000159	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EGFR—malignant glioma	4.87e-05	0.000159	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—APC—malignant glioma	4.87e-05	0.000158	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN2B—malignant glioma	4.84e-05	0.000158	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—AKT2—malignant glioma	4.83e-05	0.000157	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGF—malignant glioma	4.81e-05	0.000157	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTPN11—malignant glioma	4.79e-05	0.000156	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTK2—malignant glioma	4.7e-05	0.000153	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CD—malignant glioma	4.64e-05	0.000151	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HES1—malignant glioma	4.62e-05	0.00015	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—KRAS—malignant glioma	4.6e-05	0.00015	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NCOR1—malignant glioma	4.59e-05	0.000149	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—BRAF—malignant glioma	4.58e-05	0.000149	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CAV1—malignant glioma	4.48e-05	0.000146	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—AKT2—malignant glioma	4.46e-05	0.000145	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—FGF2—malignant glioma	4.44e-05	0.000144	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PDGFRA—malignant glioma	4.4e-05	0.000143	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—malignant glioma	4.29e-05	0.00014	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CD—malignant glioma	4.28e-05	0.000139	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SPP1—malignant glioma	4.27e-05	0.000139	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—COX8A—malignant glioma	4.27e-05	0.000139	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PIK3CA—malignant glioma	4.23e-05	0.000138	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—BCL2—malignant glioma	4.22e-05	0.000137	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IFNG—malignant glioma	4.18e-05	0.000136	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MDM2—malignant glioma	4.15e-05	0.000135	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—RAF1—malignant glioma	4.14e-05	0.000135	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—FGF2—malignant glioma	4.1e-05	0.000133	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ERBB2—malignant glioma	4.1e-05	0.000133	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CG—malignant glioma	4.08e-05	0.000133	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TERT—malignant glioma	4.05e-05	0.000132	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CB—malignant glioma	4.04e-05	0.000132	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PDGFB—malignant glioma	3.95e-05	0.000129	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PPARG—malignant glioma	3.94e-05	0.000128	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FGFR1—malignant glioma	3.93e-05	0.000128	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—AKT1—malignant glioma	3.91e-05	0.000127	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HIF1A—malignant glioma	3.87e-05	0.000126	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MDM2—malignant glioma	3.84e-05	0.000125	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—RAF1—malignant glioma	3.82e-05	0.000124	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.82e-05	0.000124	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ERBB2—malignant glioma	3.78e-05	0.000123	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CAV1—malignant glioma	3.74e-05	0.000122	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CB—malignant glioma	3.73e-05	0.000121	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL1B—malignant glioma	3.73e-05	0.000121	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL2—malignant glioma	3.71e-05	0.000121	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KDR—malignant glioma	3.7e-05	0.00012	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTGS2—malignant glioma	3.7e-05	0.00012	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ASMT—malignant glioma	3.63e-05	0.000118	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CD—malignant glioma	3.59e-05	0.000117	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—F2—malignant glioma	3.56e-05	0.000116	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FN1—malignant glioma	3.56e-05	0.000116	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.55e-05	0.000115	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—BAD—malignant glioma	3.52e-05	0.000115	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PTEN—malignant glioma	3.49e-05	0.000114	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOTCH1—malignant glioma	3.49e-05	0.000113	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—AKT1—malignant glioma	3.46e-05	0.000112	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CD80—malignant glioma	3.42e-05	0.000111	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—BCAN—malignant glioma	3.41e-05	0.000111	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APC—malignant glioma	3.41e-05	0.000111	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CG—malignant glioma	3.41e-05	0.000111	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGF—malignant glioma	3.37e-05	0.00011	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTPN11—malignant glioma	3.35e-05	0.000109	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—COX8A—malignant glioma	3.3e-05	0.000107	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTEN—malignant glioma	3.22e-05	0.000105	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—BRAF—malignant glioma	3.21e-05	0.000104	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CB—malignant glioma	3.13e-05	0.000102	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—STAT3—malignant glioma	3.12e-05	0.000102	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKT2—malignant glioma	3.12e-05	0.000102	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS2—malignant glioma	3.1e-05	0.000101	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CD—malignant glioma	3e-05	9.76e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—STAT3—malignant glioma	2.88e-05	9.38e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FGF2—malignant glioma	2.87e-05	9.34e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGFR—malignant glioma	2.84e-05	9.24e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ASMT—malignant glioma	2.8e-05	9.12e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—IDH2—malignant glioma	2.75e-05	8.95e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTEN—malignant glioma	2.7e-05	8.79e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MDM2—malignant glioma	2.69e-05	8.74e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KRAS—malignant glioma	2.68e-05	8.73e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MYC—malignant glioma	2.68e-05	8.72e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RAF1—malignant glioma	2.68e-05	8.71e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ERBB2—malignant glioma	2.65e-05	8.62e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—BCAN—malignant glioma	2.63e-05	8.57e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGFR—malignant glioma	2.62e-05	8.53e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CB—malignant glioma	2.61e-05	8.5e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.59e-05	8.44e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP2B6—malignant glioma	2.59e-05	8.42e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCL8—malignant glioma	2.51e-05	8.17e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—KRAS—malignant glioma	2.48e-05	8.06e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CA—malignant glioma	2.46e-05	8.02e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CASP3—malignant glioma	2.4e-05	7.82e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL2—malignant glioma	2.4e-05	7.81e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—IDH1—malignant glioma	2.37e-05	7.7e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SPHK1—malignant glioma	2.29e-05	7.45e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CA—malignant glioma	2.28e-05	7.4e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MMP9—malignant glioma	2.27e-05	7.39e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTEN—malignant glioma	2.26e-05	7.35e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP2C18—malignant glioma	2.24e-05	7.3e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—IDH2—malignant glioma	2.12e-05	6.91e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.11e-05	6.88e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—malignant glioma	2.04e-05	6.64e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—STAT3—malignant glioma	2.02e-05	6.57e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—AKT1—malignant glioma	2.01e-05	6.55e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP2B6—malignant glioma	2e-05	6.5e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.93e-05	6.27e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CA—malignant glioma	1.91e-05	6.2e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MYC—malignant glioma	1.88e-05	6.11e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.86e-05	6.05e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—AKT1—malignant glioma	1.86e-05	6.05e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGFR—malignant glioma	1.84e-05	5.97e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—IDH1—malignant glioma	1.83e-05	5.94e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTT1—malignant glioma	1.81e-05	5.9e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SPHK1—malignant glioma	1.77e-05	5.75e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KRAS—malignant glioma	1.73e-05	5.64e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.73e-05	5.63e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS1—malignant glioma	1.7e-05	5.53e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.69e-05	5.51e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CA—malignant glioma	1.59e-05	5.18e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—BCHE—malignant glioma	1.58e-05	5.14e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC5A5—malignant glioma	1.56e-05	5.08e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AKT1—malignant glioma	1.56e-05	5.06e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—malignant glioma	1.54e-05	5.02e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.48e-05	4.8e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.46e-05	4.76e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTT1—malignant glioma	1.4e-05	4.56e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS1—malignant glioma	1.31e-05	4.27e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKT1—malignant glioma	1.3e-05	4.23e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.28e-05	4.15e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTP1—malignant glioma	1.26e-05	4.09e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CAT—malignant glioma	1.22e-05	3.98e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—BCHE—malignant glioma	1.22e-05	3.97e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.2e-05	3.92e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NCOR1—malignant glioma	1.16e-05	3.76e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTP1—malignant glioma	9.7e-06	3.16e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CAT—malignant glioma	9.44e-06	3.07e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CAV1—malignant glioma	9.42e-06	3.06e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9e-06	2.93e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NCOR1—malignant glioma	8.92e-06	2.9e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CG—malignant glioma	8.58e-06	2.79e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPARG—malignant glioma	8.28e-06	2.69e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CD—malignant glioma	7.54e-06	2.45e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CAV1—malignant glioma	7.27e-06	2.37e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CG—malignant glioma	6.62e-06	2.15e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CB—malignant glioma	6.57e-06	2.14e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS2—malignant glioma	6.51e-06	2.12e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPARG—malignant glioma	6.39e-06	2.08e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CD—malignant glioma	5.82e-06	1.89e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTEN—malignant glioma	5.68e-06	1.85e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CB—malignant glioma	5.07e-06	1.65e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS2—malignant glioma	5.03e-06	1.64e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTEN—malignant glioma	4.38e-06	1.43e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CA—malignant glioma	4.01e-06	1.3e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AKT1—malignant glioma	3.27e-06	1.07e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CA—malignant glioma	3.09e-06	1.01e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AKT1—malignant glioma	2.53e-06	8.22e-06	CbGpPWpGaD
